Patient Death In New Alzheimer’s Drug Aduhelm : Hands to Help Seniors
Blogs on News & Media


What We Do
Help Support Our Seniors
Find Help
News & Media
About Hands to Help Seniors

831-204-0402

Tell a friend about this page

Patient Death In New Alzheimer’s Drug Aduhelm

by Richard Kuehn on 11/11/21

There was much excitement when the FDA approved a new drug called Aduhelm to treat patients with Alzheimer’s disease.  Although there was some debate over its efficacy, the fact that there have been no new drugs brought to market to treat this horrible disease in decades had some filled with hope.  However, Biogen Inc., the pharmaceutical company who makes the drug, admitted this week that there was one death linked to Aduhelm.  The company announced that a 75-year old who took the drug was hospitalized and diagnosed with swelling in the brain before dying.  It’s unclear that the brain swelling was linked to the drug, however, there is sure to be an investigation due to the fact that brain swelling, also known as ARIA-E, was cited as one of the most common side effects during testing of the drug. 

 

https://www.wsj.com/articles/biogen-investigates-death-of-aduhelm-patient-11636479862

Comments (0)


Leave a comment


What We DoHelp Support Our SeniorsFind HelpNews & MediaAbout Hands to Help Seniors

Copyright © 2010 to 2020 Hands to Help Seniors Inc. All Rights Reserved.
Hands to Help Seniors, Inc. is a not-for-profit 501(c)(3) organization, our Tax ID # is 45-2403819